SE0102858D0 - N-type calcium channel antagonists for the treatment of pain - Google Patents

N-type calcium channel antagonists for the treatment of pain

Info

Publication number
SE0102858D0
SE0102858D0 SE0102858A SE0102858A SE0102858D0 SE 0102858 D0 SE0102858 D0 SE 0102858D0 SE 0102858 A SE0102858 A SE 0102858A SE 0102858 A SE0102858 A SE 0102858A SE 0102858 D0 SE0102858 D0 SE 0102858D0
Authority
SE
Sweden
Prior art keywords
sup
treatment
pain
calcium channel
type calcium
Prior art date
Application number
SE0102858A
Other languages
English (en)
Inventor
Amico Derin D
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0102858A priority Critical patent/SE0102858D0/sv
Publication of SE0102858D0 publication Critical patent/SE0102858D0/sv
Priority to PCT/SE2002/001521 priority patent/WO2003018561A1/en
Priority to AT02760975T priority patent/ATE295837T1/de
Priority to JP2003523224A priority patent/JP2005508894A/ja
Priority to EP02760975A priority patent/EP1430030B1/en
Priority to US10/488,025 priority patent/US7153865B2/en
Priority to DE60204232T priority patent/DE60204232T2/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/47064-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • C07D215/44Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
SE0102858A 2001-08-27 2001-08-27 N-type calcium channel antagonists for the treatment of pain SE0102858D0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE0102858A SE0102858D0 (sv) 2001-08-27 2001-08-27 N-type calcium channel antagonists for the treatment of pain
PCT/SE2002/001521 WO2003018561A1 (en) 2001-08-27 2002-08-23 N-type calcium channel antagonists for the treatment of pain
AT02760975T ATE295837T1 (de) 2001-08-27 2002-08-23 Antagonisten für calciumkanäle vom n-typ zur behandlung von schmerzen
JP2003523224A JP2005508894A (ja) 2001-08-27 2002-08-23 痛みの治療のためのn型カルシウムチャネルアンタゴニスト
EP02760975A EP1430030B1 (en) 2001-08-27 2002-08-23 N-type calcium channel antagonists for the treatment of pain
US10/488,025 US7153865B2 (en) 2001-08-27 2002-08-23 N-type calcium channel antagonists for the treatment of pain
DE60204232T DE60204232T2 (de) 2001-08-27 2002-08-23 Antagonisten für calciumkanäle vom n-typ zur behandlung von schmerzen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0102858A SE0102858D0 (sv) 2001-08-27 2001-08-27 N-type calcium channel antagonists for the treatment of pain

Publications (1)

Publication Number Publication Date
SE0102858D0 true SE0102858D0 (sv) 2001-08-27

Family

ID=20285150

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0102858A SE0102858D0 (sv) 2001-08-27 2001-08-27 N-type calcium channel antagonists for the treatment of pain

Country Status (7)

Country Link
US (1) US7153865B2 (sv)
EP (1) EP1430030B1 (sv)
JP (1) JP2005508894A (sv)
AT (1) ATE295837T1 (sv)
DE (1) DE60204232T2 (sv)
SE (1) SE0102858D0 (sv)
WO (1) WO2003018561A1 (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002361846A1 (en) * 2001-12-21 2003-07-15 Bayer Pharmaceuticals Corporation Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
US7223754B2 (en) 2003-03-10 2007-05-29 Dynogen Pharmaceuticals, Inc. Thiazolidinone, oxazolidinone, and imidazolone derivatives for treating lower urinary tract and related disorders
US7084116B2 (en) 2003-03-10 2006-08-01 Dynogen Pharmaceuticals, Inc. Methods for treating lower urinary tract disorders and the related disorders vulvodynia and vulvar vestibulitis using Cav2.2 subunit calcium channel modulators
MXPA05009722A (es) * 2003-03-10 2006-03-09 Schering Corp Inhibidores heterociclicos de cinasa: metodos de uso y sintesis.
WO2005000285A2 (en) * 2003-06-13 2005-01-06 Dynogen Pharmaceuticals, Inc. METHODS OF TREATING NON-INFLAMMATORY GASTROINTESTINAL TRACT DISORDERS USING Cav2.2 SUBUNIT CALCIUM CHANNEL MODULATORS
US20060128702A1 (en) * 2004-11-23 2006-06-15 Manojit Pal Heterocyclic and bicyclic compounds, compositions and methods
AU2006329040C1 (en) 2005-12-22 2011-12-08 Newron Pharmaceuticals S.P.A. 2 -Phenylethylamino derivatives as calcium and/or sodium channel modulators
CN101687773B (zh) 2007-06-15 2014-07-30 纽朗制药有限公司 取代的2-[2-(苯基)乙氨基]烷酰胺衍生物及其作为钠和/或钙通道调节剂的应用
US8987301B2 (en) 2009-11-07 2015-03-24 Merck Patent Gmbh Heteroarylaminoquinolines as TGF-beta receptor kinase inhibitors
ME02524B (me) 2011-06-27 2017-02-20 Newron Pharm Spa Fluorisani derivati arilalkilaminokarboksamida
EP3632426A1 (en) 2013-02-01 2020-04-08 Wellstat Therapeutics Corporation Amine compounds having anti-inflammatory, antifungal, antiparasitic and anticancer activity
CN105407894A (zh) 2013-03-14 2016-03-16 康威基内有限公司 用于抑制含布罗莫结构域的蛋白质的方法和组合物
ES2918589T3 (es) 2015-11-25 2022-07-19 Convergene Llc Inhibidores de bromodomios BET bicíclicos y usos de los mismos
WO2019045655A1 (en) * 2017-08-29 2019-03-07 Chulabhorn Foundation DERIVATIVES AND COMPOSITION OF QUINOLINE AND NAPHTHYRIDINE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1573186A (en) * 1977-09-14 1980-08-20 Wyeth John & Brother Ltd 4-aminoquinoline derivatives
AU4802500A (en) * 1999-04-26 2000-11-10 Neurogen Corporation 2-aminoquinolinecarboxamides: neurokinin receptor ligands

Also Published As

Publication number Publication date
US20050131020A1 (en) 2005-06-16
JP2005508894A (ja) 2005-04-07
WO2003018561A1 (en) 2003-03-06
EP1430030A1 (en) 2004-06-23
US7153865B2 (en) 2006-12-26
DE60204232D1 (de) 2005-06-23
ATE295837T1 (de) 2005-06-15
DE60204232T2 (de) 2006-01-26
EP1430030B1 (en) 2005-05-18

Similar Documents

Publication Publication Date Title
SE0004053D0 (sv) N-type calcium channel antagonists for the treatment of pain
EA200401169A1 (ru) Аминометилзамещенные тетрациклиновые соединения
NO20026064D0 (no) Nye forbindelser
SE9504661D0 (sv) New compounds
DE60334379D1 (de) Copolymerverbindung, diese enthaltende polymerzusammensetzung, bilderzeugungsverfahren und dieselbe benutzende bilderzeugungsvorrichtung
ATE365703T1 (de) Substituierte 1,3-diphenylprop-2-en-1-on derivate,deren herstellung und anwendungen
PT1157037E (pt) Conjugados de gcsf
SE0102858D0 (sv) N-type calcium channel antagonists for the treatment of pain
SE9802729D0 (sv) Novel Compounds
SE0302139D0 (sv) Novel compounds
SE0004054D0 (sv) N-type calcium channel antagonists for the treatment of pain
SE9802208D0 (sv) Novel compounds
YU13301A (sh) Muskarinski agonisti i antagonisti
AR021695A1 (es) 4,5-pirazinoxindoles, composicion farmaceutica y uso
SE0003476D0 (sv) Compounds
SE0101038D0 (sv) Novel compounds
SE0301320D0 (sv) Positive modulators of nicotinic acetylcholine receptors
SE0203070D0 (en) Novel compounds
DE50310579D1 (de) Furancarboxamide
DK1532131T3 (da) Motilid-forbindelser
SE0303280D0 (sv) Novel compounds
SE0203300D0 (sv) Novel Compounds
SE0302755D0 (sv) Novel compounds
DE50311756D1 (de) Mikrobizide oxathiincarboxamide
SE0004055D0 (sv) N-type calcium channel antagonists for the treatment of pain